A001630 Overzicht aandelen
Chong Kun Dang Holdings Corp. produceert en distribueert farmaceutische producten in Zuid-Korea en internationaal.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 1/6 |
| Dividenden | 2/6 |
Beloningen
Risicoanalyse
Chong Kun Dang Holdings Corp. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₩55,000.00 |
| 52 Week Hoogtepunt | ₩64,300.00 |
| 52 Week Laag | ₩47,150.00 |
| Bèta | 0.57 |
| 11 maand verandering | -3.34% |
| 3 maanden verandering | 10.44% |
| 1 Jaar Verandering | -2.14% |
| 33 jaar verandering | -32.35% |
| 5 jaar verandering | -38.06% |
| Verandering sinds IPO | 79.26% |
Recent nieuws en updates
Benign Growth For Chong Kun Dang Holdings Corp. (KRX:001630) Underpins Its Share Price
Aug 06
We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings
Mar 27Recent updates
Benign Growth For Chong Kun Dang Holdings Corp. (KRX:001630) Underpins Its Share Price
Aug 06We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings
Mar 27Here's Why Chong Kun Dang Holdings (KRX:001630) Has A Meaningful Debt Burden
Apr 28Could Chong Kun Dang Holdings Corp. (KRX:001630) Have The Makings Of Another Dividend Aristocrat?
Apr 08Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Is An Interesting Stock
Mar 01The Chong Kun Dang Holdings (KRX:001630) Share Price Has Gained 54% And Shareholders Are Hoping For More
Feb 14Is Weakness In Chong Kun Dang Holdings Corp. (KRX:001630) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 01Chong Kun Dang Holdings (KRX:001630) Has A Pretty Healthy Balance Sheet
Jan 19Should Chong Kun Dang Holdings Corp. (KRX:001630) Be Part Of Your Dividend Portfolio?
Jan 06
Do Institutions Own Chong Kun Dang Holdings Corp. (KRX:001630) Shares?
Dec 24Chong Kun Dang Holdings's (KRX:001630) Earnings Are Growing But Is There More To The Story?
Dec 11Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Might Deserve Your Attention Today
Nov 28Rendement voor aandeelhouders
| A001630 | KR Pharmaceuticals | KR Markt | |
|---|---|---|---|
| 7D | -1.3% | -3.0% | -1.2% |
| 1Y | -2.1% | 25.6% | 4.8% |
Rendement versus industrie: A001630 underperformed the KR Pharmaceuticals industry which returned 25.6% over the past year.
Rendement versus markt: A001630 underperformed the KR Market which returned 4.8% over the past year.
Prijsvolatiliteit
| A001630 volatility | |
|---|---|
| A001630 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.2% |
| 10% least volatile stocks in KR Market | 3.5% |
Stabiele aandelenkoers: A001630 has not had significant price volatility in the past 3 months compared to the KR market.
Volatiliteit in de loop van de tijd: A001630's weekly volatility (5%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1941 | 37 | n/a | www.ckd-holdings.com/company/summary.do |
Chong Kun Dang Holdings Corp. produceert en distribueert farmaceutische producten in Zuid-Korea en internationaal. Het bedrijf werd opgericht in 1941 en is gevestigd in Seoul, Zuid-Korea.
Chong Kun Dang Holdings Corp. Samenvatting
| A001630 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₩261.83b |
| Inkomsten(TTM) | ₩48.13b |
| Inkomsten(TTM) | ₩946.09b |
5.4x
Koers/Winstverhouding0.3x
P/S-verhoudingIs A001630 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| A001630 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₩946.09b |
| Kosten van inkomsten | ₩521.72b |
| Brutowinst | ₩424.37b |
| Overige uitgaven | ₩376.24b |
| Inkomsten | ₩48.13b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 10.11k |
| Brutomarge | 44.86% |
| Nettowinstmarge | 5.09% |
| Schuld/Eigen Vermogen Verhouding | 55.7% |
Hoe presteerde A001630 op de lange termijn?
Bekijk historische prestaties en vergelijking